Depreciation of Hepion Pharmaceuticals, Inc. from 30 Jun 2015 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Hepion Pharmaceuticals, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Jun 2015 to 31 Dec 2024.
  • Hepion Pharmaceuticals, Inc. Depreciation for the quarter ending 31 Dec 2024 was $69,242, a 53% increase year-over-year.
  • Hepion Pharmaceuticals, Inc. Depreciation for the twelve months ending 31 Dec 2024 was $100,000, unchanged year-over-year.
  • Hepion Pharmaceuticals, Inc. annual Depreciation for 2024 was $100,000, unchanged from 2023.
  • Hepion Pharmaceuticals, Inc. annual Depreciation for 2023 was $100,000, unchanged from 2022.
  • Hepion Pharmaceuticals, Inc. annual Depreciation for 2022 was $100,000, unchanged from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Hepion Pharmaceuticals, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $100,000 $69,242 +$24,107 +53% 01 Oct 2024 31 Dec 2024 10-K 08 Apr 2025 2024 FY
Q3 2024 $75,893 $0 -$18,500 -100% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $94,393 $0 -$18,328 -100% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $112,721 $30,758 +$12,721 +71% 01 Jan 2024 31 Mar 2024 10-Q 21 May 2024 2024 Q1
Q4 2023 $100,000 $45,135 +$4,120 +10% 01 Oct 2023 31 Dec 2023 10-K 08 Apr 2025 2024 FY
Q3 2023 $95,880 $18,500 +$774 +4.4% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $95,106 $18,328 -$201 -1.1% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $95,307 $18,037 -$4,693 -21% 01 Jan 2023 31 Mar 2023 10-Q 21 May 2024 2024 Q1
Q4 2022 $100,000 $41,015 +$3,673 +9.8% 01 Oct 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 $96,327 $17,726 -$5,380 -23% 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023 2023 Q3
Q2 2022 $101,707 $18,529 -$2,880 -13% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $104,587 $22,730 +$4,587 +25% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q4 2021 $100,000 $37,342 01 Oct 2021 31 Dec 2021 10-K 10 Apr 2023 2022 FY
Q3 2021 $23,106 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $21,409 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $18,143 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1

Hepion Pharmaceuticals, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $100,000 $0 0% 01 Jan 2024 31 Dec 2024 10-K 08 Apr 2025 2024 FY
2023 $100,000 $0 0% 01 Jan 2023 31 Dec 2023 10-K 08 Apr 2025 2024 FY
2022 $100,000 $0 0% 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
2021 $100,000 +$65,485 +190% 01 Jan 2021 31 Dec 2021 10-K 10 Apr 2023 2022 FY
2020 $34,515 01 Jan 2020 31 Dec 2020 10-K 08 Apr 2022 2021 FY
2017 $27,993 +$6,468 +30% 01 Jul 2016 30 Jun 2017 10-KT 26 Mar 2018 2017 FY
2016 $21,525 +$5,170 +32% 01 Jul 2015 30 Jun 2016 10-KT 26 Mar 2018 2017 FY
2015 $16,355 01 Jul 2014 30 Jun 2015 10-K 28 Sep 2016 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.